Effects of apoE on neuronal signaling and APP processing in rodent brain

Brain Research

Volumn 1112, Issue 1, 2006, Pages 70-79

  Hoe, Hyang Sook ^a   Pocivavsek, Ana ^a   Dai, Haining ^a   Chakraborty, Geetanjali ^a   Harris, D Christopher ^a   Rebeck, G William ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E RECEPTOR; APOLIPOPROTEIN E RECEPTOR 2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; MICROSPHERE; MITOGEN ACTIVATED PROTEIN KINASE; RECEPTOR SUBUNIT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; RODENT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCYTOSIS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; PEPTIDES; PHOSPHOPYRUVATE HYDRATASE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, LIPOPROTEIN; SIGNAL TRANSDUCTION; TIME FACTORS;

RODENTIA;

EID: 33748430000     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.035     Document Type: Article

References (40)

1. Arnaud L., Ballif B.A., Forster E., and Cooper J.A. Regulation of protein tyrosine kinase signaling by substrate degradation during brain development. Mol. Cell. Biol. 23 (2003) 9293-9302
2. Bacskai B.J., Xia M.Q., Strickland D.K., Rebeck G.W., and Hyman B.T. The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. 97 (2000) 551-556
3. Beffert U., Weeber E.J., Morfini G., Ko J., Brady S.T., Tsai L.H., Sweatt J.D., and Herz J. Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J. Neurosci. 24 (2004) 1897-1906
4. Benhayon D., Magdaleno S., and Curran T. Binding of purified Reelin to ApoEr2 and VLDLR mediates tyrosine phosphorylation of Disabled-1. Brain Res. Mol. Brain Res. 112 (2003) 33-45
5. Bock H.H., and Herz J. Reelin activates Src family tyrosine kinases in neurons. Curr. Biol. 13 (2003) 18-26
6. Buttini M., Orth M., Bellosta S., Akeefe H., Pitas R.E., Wyss-Coray T., Mucke L., and Mahley R.W. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19 (1999) 4867-4880
7. Chen S., Averett N.T., Manelli A., LaDu M.J., May W., and Ard M.D. Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia. J. Alzheimers Dis. 7 (2005) 25-35
8. Danik M., and Poirier J. Apolipoprotein E and neuronal plasticity following experimental de-afferentation and in Alzheimer's disease. Biochem. Soc. Trans. 26 (1998) 262-266
9. Ferrer I., Blanco R., Carmona M., and Puig B. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p-38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J. Neural Transm. 108 (2001) 1397-1415
10. Fukumoto H., Ingelsson M., Garevik N., Wahlund L.O., Nukina N., Yaguchi Y., Shibata M., Hyman B.T., Rebeck G.W., and Irrizary M.C. APOE epsilon 3/epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis. Exp. Neurol. 183 (2003) 249-253
11. Guo L., LaDu M.J., and Van Eldik L.J. A dual role for apolipoprotein E in neuroinflammation: anti- and pro-inflammatory activity. J. Mol. Neurosci. 23 (2004) 205-212
12. Herrick T.M., and Copper J.A. A hypomorphic allele of dab1 reveals regional differences in reelin-Dab1 signaling during brain development. Development 129 (2002) 787-796
13. Herz J., and Beffert U. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat. Rev., Neurosci. 1 (2000) 51-58
14. Hoe H.S., and Rebeck G.W. Regulation of ApoE receptor proteolysis by ligand binding. Brain Res. Mol. Brain Res. 137 (2005) 31-39
15. Hoe H.S., Harris D.C., and Rebeck G.W. Multiple pathways of apolipoprotein E signaling in primary neurons. J. Neurochem. 93 (2005) 145-155
16. Howell B.W., Herrick T.M., and Copper J.A. Reelin-induced tyrosine phosphorylation of disabled-1 during neuronal positioning. Genes Dev. 15 (1999) 643-648
17. Hyman B.T., Strickland D.K., and Rebeck G.W. Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer's disease. Arch. Neurol. 57 (2000) 646-650
18. Irizarry M.C., Deng A., Lleo A., Berezovska O., Von Arnim C.A., Martin-Rehrmann M., Manelli A., LaDu M.J., Hyman B.T., and Rebeck G.W. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein. J. Neurochem. 90 (2004) 1132-1143
19. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., Higgs R., Liu F., Malkani S., Bales K.R., and Paul S.M. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10 (2004) 719-726
20. LaDu M.J., Shah J.A., Reardon C.A., Getz G.S., Bu G., Hu J., Guo L., and Van Eldik L.J. Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem. Int. 39 (2001) 427-434
21. Levi O., Jongen-Relo A.L., Feldon J., Roses A.D., and Michaelson D.M. ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol. Dis. 13 (2003) 273-282
22. Li, F.Q., Sempowski, G.D., Mckenna, S.E., Laskowitz, D.T., Colton, C.A., Vitek, M.P., in press. Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. Pharmacol. Exp. Ther.
23. Lillis A.P., Mikhailenko I., and K. S.D. Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J. Thromb. Haemost. 3 (2005) 1884-1893
24. Lynch J.R., Tang W., Wang H., Vitek M.P., Bennett E.R., Sullivan P.M., Warner D.S., and Laskowitz D.T. ApoE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J. Biol. Chem. 278 (2003) 48529-48533
25. Lynch J.R., Wang H., Mace B., Leinenweber S., Warner D.S., Bennett E.R., Vitek M.P., McKenna S., and Laskowitz D.T. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp. Neurol. 192 (2005) 109-116
26. Moulder K.L., Narita M., Chang L.K., Bu G., and Johnson E.M.J. Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide. J. Neurochem. 72 (1999) 1069-1080
27. Narita M., Bu G., Holtzman D.M., and Schwartz A.L. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development. J. Neurochem. 68 (1997) 587-595
28. Ohkubo N., Mitsuda N., Tamatani M., Yamaguchi A., Lee Y.D., Ogihara T., Vitek M.P., and Tohyama M. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J. Biol. Chem. 276 (2001) 3046-3053
29. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego, CA
30. Pei J.J., Braak H., An W.L., Winblad B., Cowburn R.F., and Iqbal K. Grundke-Iqbal, I., Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res. Mol. Brain Res. 30 (2002) 45-55
31. Postuma R.B., Martins R.N., Cappai R., Beyreuther K., Masters C.L., Strickland D.K., Mok S.S., and Small D.H. Effects of the amyloid protein precursor of Alzheimer's disease and other ligands of the LDL receptor-related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett. 428 (1998) 13-16
32. Qiu Z., Strickland D.K., Hyman B.T., and Rebeck G.W. Alpha 2-macroglobulin exposure reduces calcium responses to N-methyl-d-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. J. Biol. Chem. 277 (2002) 14458-14466
33. Qiu Z., Hyman B.T., and Rebeck G.W. Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinases in primary neurons. J. Biol. Chem. 279 (2004) 34948-34956
34. Sullivan P.M., Mace B.E., Maeda N., and Schmechel D.E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 124 (2004) 725-733
35. Teter B., Xu P.T., Gilbert J.R., Roses A.D., Galasko D., and Cole G.M. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J. Neurosci. Res. 68 (2002) 331-336
36. Tolar M., Keller J.N., Chan S., Mattson M.P., Marques M.A., and Crutcher K.A. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J. Neurosci. 19 (1999) 7100-7110
37. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., and Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97 (1999) 689-701
38. Wahrle S.E., Jiang H., Parsadanian M., Legleiter J., Han X., Fryer J.D., Kowalewski T., and Holtzman D.M. ABCA1 is required for normal central nervous system apoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279 (2004) 40987-40993
39. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., and Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277 (2002) 39944-39952
40. Zhu X., Castellani R.J., Takeda A., Nunomura A., Atwood C.S., Perry G., and Smith M.A. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer's disease: the 'two hit' hypothesis. Mech. Ageing Dev. 123 (2001) 39-46